longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

G Medical Innovations Holdings Ltd

GMVDF

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.20, within the reasonable range, cheaper than 47.51% of the time in the past 5 years, and the industry ranks 30/74, the industry Median --.

-0.199xP/E
$0.00Stock price
$-0.00Earnings per share
-0.199xP/E
Stock price$0.00Earnings per share$-0.00

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.24x
Typical range
-0.64x–-0.20x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-47.07x2.92%$21.34B
HIMSUSHims & Hers Health
-45.08x209.86%$6.40B
RDNTUSRadnet
-276.83x128.00%$5.85B
WGSUSGeneDx
-23.54x359.59%$2.50B
NEOUSNeogenomics
-43.61x64.46%$2.26B
AGLUSagilon health
-6.70x93.67%$1.55B
INNVUSInnovage
-567.13x2,225.00%$1.44B
OPKUSOpko Health
-15.26x25.44%$1.11B
LMRIUSLumexa Imaging
-38.77x146.66%$1.08B
CSTLUSCastle Biosciences
-50.86x53.28%$987.36M
GMRSUSGMR Solutions
-8.90x91.45%$673.65M
FLGTUSFulgent Genetics
-6.56x42.64%$553.61M
PREUSPrenetics Global
-8.50x19.04%$399.24M
AONCUSAmerican Oncology Network
----$336.99M
BDSXUSBiodesix
-9.90x42.77%$274.75M
GAMGUSGlobal Asset Management Group, Inc.
-335.24x--$189.22M
AIRSUSAirSculpt Tech
-14.74x33.33%$173.03M
NAKAUSNakamoto
-0.33x101.83%$138.86M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-28.64x--$101.24M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.